News
Impact of PDB Structures on Anti-Cancer Drug Approvals
12/02 
A new flyer highlights the Impact of PDB Structures on US FDA Anti-Cancer Drug Approvals (2010-2023) (PDF).
For more, see
- Impact of structural biology and the Protein Data Bank on US FDA new drug approvals of low molecular weight antineoplastic agents 2019–2023
(2024) Oncogene 43: 2229-2243 doi: 10.1038/s41388-024-03077-2 - Impact of the Protein Data Bank on antineoplastic approvals
(2020) Drug Discovery Today 25:837-850 doi: 10.1016/j.drudis.2020.02.002















